title: The Medicare prescription drug proposals and health insurance risk.
abstract: In order to facilitate a better understanding of the complex issues raised by the current Senate and House proposals to establish a prescription drug benefit for Medicare beneficiaries, this paper briefly addresses some fundamentals of the health insurance market, defines key risk-sharing mechanisms, including risk corridors and reinsurance, and identifies the relevant risk provisions in the bills. Other issues related to cost management strategies and program design, which may have an impact on cost and adverse selection, are briefly discussed.
authors.forename: Dawn M
authors.initials: DM
authors.lastname: Gencarelli
mesh_terms: D003365:Costs and Cost Analysis / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D007342:Insurance Benefits / Q000191:economics* / Q000331:legislation & jurisprudence; D019458:Insurance Coverage / Q000191:economics* / Q000331:legislation & jurisprudence; D007356:Insurance, Pharmaceutical Services / Q000191:economics* / Q000331:legislation & jurisprudence; D006278:Medicare / Q000191:economics* / Q000331:legislation & jurisprudence; D012306:Risk; D020414:Risk Sharing, Financial / Q000191:economics / Q000331:legislation & jurisprudence; D014481:United States